Health
Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan – Reuters India
Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
(Reuters) – Pfizer Inc (PFE.N) and BioNTech SE (BNTX.O) have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery.
The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 p…
-
Business14 hours ago10 ASX shares to buy after the market selloff
-
General17 hours ago‘We are here for you’: PM to bring help to flood zones
-
General16 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General13 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains